Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
OSCR Stock Summary
Top 10 Correlated ETFs
OSCR
In the News
Why Fast-paced Mover Oscar Health, Inc. (OSCR) Is a Great Choice for Value Investors
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Oscar Health, Inc. (OSCR) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Despite Fast-paced Momentum, Oscar Health, Inc. (OSCR) Is Still a Bargain Stock
Oscar Health, Inc. (OSCR) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Oscar Health, Inc. (OSCR) Q4 2023 Earnings Call Transcript
Oscar Health, Inc. (OSCR) Q4 2023 Earnings Call Transcript
The 3 Best Insurance Stocks to Buy Now: January 2024
Looking for the best insurance stocks to buy in January 2024? Some say that “risk happens slowly, then all at once.
Oscar Health: Flexible Business Model Is Paying Off
Oscar Health offers an innovative healthcare insurance platform using AI and big data to match plans to individual situations, producing high patient satisfaction. Membership growth has stalled due to portfolio sculpting efforts but is likely to resume. The company plans to expand in existing markets and introduce new programs, leveraging its existing network of providers.
Oscar Health, Inc. (OSCR) Is Attractively Priced Despite Fast-paced Momentum
Oscar Health, Inc. (OSCR) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Oscar Health, Inc. (OSCR) Shows Fast-paced Momentum But Is Still a Bargain Stock
Oscar Health, Inc. (OSCR) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
November Marks Best Month Since 2022: 4 Best Sectors & Stock Picks
November marked an exceptional month for stocks. Interest rate-sensitive sectors and stocks like Udemy (UDMY), Oscar Health (OSCR), Rocky Brands (RCKY) and Landsea Homes (LSEA) outperformed in the month.
Oscar Health, Inc.: On Path To Profitability Through Strategic Margins And Unique Technology
Consider buying Oscar Health before it achieves consistent positive earnings, as higher valuation will limit potential future gains. While yet to turn a profit, recent positive adjusted EBITDA and management focus on profitability and faster growth signal potential for positive net income in the next 1-2 years. Margin Improvement Focus: Oscar Health's strategy of pricing above peers, leveraging Medicaid redeterminations, and targeting lower Medical Loss Ratio, aims to boost margins.
Oscar Health, Inc. (OSCR) is a Great Momentum Stock: Should You Buy?
Does Oscar Health, Inc. (OSCR) have what it takes to be a top stock pick for momentum investors? Let's find out.
OSCR Financial details
OSCR Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2.73 | 20.15 | 10.73 | 19.42 | 26.45 | |
Net income per share | -1.29 | -13.9 | -3.19 | -2.87 | -1.22 | |
Operating cash flow per share | -0.81 | 7.61 | -1.02 | 1.79 | -1.23 | |
Free cash flow per share | -0.94 | 7.13 | -1.16 | 1.65 | -1.34 | |
Cash per share | 3.3 | 40.76 | 9.45 | 13.91 | 11.55 | |
Book value per share | -4.65 | -44.28 | 7.75 | 4.19 | 3.63 | |
Tangible book value per share | 4.2 | -44.28 | 16.1 | 4.2 | 3.64 | |
Share holders equity per share | -4.65 | -44.28 | 7.75 | 4.19 | 3.63 | |
Interest debt per share | 0 | 4.99 | 0.03 | 1.51 | 1.46 | |
Market cap | 7.07B | 1.02B | 1.4B | 522.69M | 2.03B | |
Enterprise value | 6.73B | 334.53M | 300.9M | -737.91M | 456.61M | |
P/E ratio | -27.07 | -2.5 | -2.46 | -0.86 | -7.49 | |
Price to sales ratio | 12.77 | 1.73 | 0.73 | 0.13 | 0.35 | |
POCF ratio | -42.75 | 4.57 | -7.73 | 1.37 | -7.45 | |
PFCF ratio | -36.94 | 4.88 | -6.77 | 1.49 | -6.81 | |
P/B Ratio | -7.48 | -0.79 | 1.01 | 0.59 | 2.52 | |
PTB ratio | -7.48 | -0.79 | 1.01 | 0.59 | 2.52 | |
EV to sales | 12.16 | 0.57 | 0.16 | -0.18 | 0.08 | |
Enterprise value over EBITDA | -26.55 | -0.85 | -0.53 | 1.3 | -1.94 | |
EV to operating cash flow | -40.71 | 1.5 | -1.66 | -1.94 | -1.68 | |
EV to free cash flow | -35.18 | 1.6 | -1.45 | -2.1 | -1.53 | |
Earnings yield | -0.04 | -0.4 | -0.41 | -1.17 | -0.13 | |
Free cash flow yield | -0.03 | 0.2 | -0.15 | 0.67 | -0.15 | |
Debt to equity | 0 | -0.11 | 0 | 0.33 | 0.37 | |
Debt to assets | 0 | 0.06 | 0 | 0.07 | 0.09 | |
Net debt to EBITDA | 1.33 | 1.73 | 1.96 | 2.22 | 6.67 | |
Current ratio | 1.47 | 2.68 | 4.25 | 1.26 | 1.29 | |
Interest coverage | 0 | -115.78 | -122.26 | -25.82 | -9.58 | |
Income quality | 0.63 | -0.55 | 0.32 | -0.62 | 1.01 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.2 | 0.28 | 0.14 | 0.08 | 0.06 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.27 | 0.18 | 0.19 | 0 | 0 | |
Capex to operating cash flow | 0.16 | -0.06 | 0.14 | -0.08 | 0.09 | |
Capex to revenue | -0.05 | -0.02 | -0.01 | -0.01 | 0 | |
Capex to depreciation | -3.77 | -1.24 | -1.77 | -1.9 | -0.83 | |
Stock based compensation to revenue | 0.06 | 0.06 | 0.04 | 0.03 | 0.03 | |
Graham number | 11.6 | 117.69 | 23.6 | 16.45 | 9.98 | |
ROIC | 0.28 | 0.35 | -0.42 | -0.49 | -0.22 | |
Return on tangible assets | -0.26 | -0.22 | -0.21 | -0.13 | -0.08 | |
Graham Net | -0.72 | -100.76 | 6.02 | -1.83 | -5.19 | |
Working capital | 231.35M | 808.36M | 1.43B | 857.63M | 632.09M | |
Tangible asset value | 491.96M | -1.69B | 2.25B | 892.4M | 806.12M | |
Net current asset value | 231.35M | -2.28B | 1.43B | 487.35M | 265.74M | |
Invested capital | 0 | -0.11 | 0 | 0.33 | 0.37 | |
Average receivables | 0 | 75.83M | 137.78M | 669.15M | 826.81M | |
Average payables | 0 | 487.54M | 460.43M | 582.75M | 529.94M | |
Average inventory | 0 | -1.01B | -952.95M | -887.03M | -2.11B | |
Days sales outstanding | 36.38 | 59.72 | 34.03 | 102.56 | 30.78 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 10.03 | 6.11 | 10.73 | 3.56 | 11.86 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.28 | 0.31 | -0.41 | -0.68 | -0.34 | |
Capex per share | -0.13 | -0.48 | -0.14 | -0.14 | -0.12 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 4.82 | 6.77 | 6.94 | 6.45 | 6.3 | |
Net income per share | -1.05 | -0.18 | -0.07 | -0.29 | -0.66 | |
Operating cash flow per share | 0.7 | 1.91 | 0.75 | -5.15 | 1.31 | |
Free cash flow per share | 0.67 | 1.88 | 0.73 | -5.18 | 1.28 | |
Cash per share | 13.74 | 15.83 | 16.31 | 10.96 | 11.27 | |
Book value per share | 4.14 | 4.29 | 4.33 | 4.12 | 3.54 | |
Tangible book value per share | 4.15 | 4.3 | 4.34 | 4.13 | 3.55 | |
Share holders equity per share | 4.14 | 4.29 | 4.33 | 4.12 | 3.54 | |
Interest debt per share | 1.41 | 1.4 | 1.39 | 1.37 | 1.34 | |
Market cap | 529.38M | 1.42B | 1.77B | 1.24B | 2.08B | |
Enterprise value | -731.22M | -392.77M | -255.31M | 141.45M | 506.26M | |
P/E ratio | -0.58 | -8.95 | -28.47 | -4.75 | -3.46 | |
Price to sales ratio | 0.51 | 0.97 | 1.16 | 0.86 | 1.45 | |
POCF ratio | 3.5 | 3.42 | 10.68 | -1.08 | 7 | |
PFCF ratio | 3.67 | 3.48 | 11.06 | -1.08 | 7.15 | |
P/B Ratio | 0.59 | 1.53 | 1.86 | 1.35 | 2.58 | |
PTB ratio | 0.59 | 1.53 | 1.86 | 1.35 | 2.58 | |
EV to sales | -0.7 | -0.27 | -0.17 | 0.1 | 0.35 | |
Enterprise value over EBITDA | 3.37 | 15.48 | 39.1 | -2.43 | -3.48 | |
EV to operating cash flow | -4.83 | -0.95 | -1.54 | -0.12 | 1.71 | |
EV to free cash flow | -5.07 | -0.96 | -1.6 | -0.12 | 1.74 | |
Earnings yield | -0.43 | -0.03 | -0.01 | -0.05 | -0.07 | |
Free cash flow yield | 0.27 | 0.29 | 0.09 | -0.93 | 0.14 | |
Debt to equity | 0.33 | 0.32 | 0.31 | 0.32 | 0.37 | |
Debt to assets | 0.07 | 0.07 | 0.07 | 0.09 | 0.09 | |
Net debt to EBITDA | 5.81 | 71.41 | 309.95 | 18.91 | 10.8 | |
Current ratio | 1.26 | 1.3 | 1.29 | 1.45 | 1.29 | |
Interest coverage | -35.96 | -4.94 | -1.07 | -9.5 | -23.4 | |
Income quality | -0.67 | -10.47 | -10.73 | 17.49 | -1.98 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.07 | 0.07 | 0.05 | 0.05 | 0.06 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.05 | -0.02 | -0.03 | 0.01 | -0.02 | |
Capex to revenue | -0.01 | -0.01 | 0 | 0 | 0 | |
Capex to depreciation | -1.91 | -1.49 | -0.64 | -0.7 | -0.79 | |
Stock based compensation to revenue | 0.03 | 0.05 | 0.02 | 0.02 | 0.02 | |
Graham number | 9.9 | 4.2 | 2.63 | 5.21 | 7.25 | |
ROIC | -0.19 | -0.03 | -0.01 | -0.05 | -0.13 | |
Return on tangible assets | -0.05 | -0.01 | 0 | -0.02 | -0.04 | |
Graham Net | -1.81 | 0.68 | 0.97 | 1.14 | -5.07 | |
Working capital | 857.63M | 949.52M | 948.32M | 930.75M | 632.09M | |
Tangible asset value | 892.4M | 931.76M | 951.97M | 921.43M | 806.12M | |
Net current asset value | 487.35M | 579.95M | 579.65M | 563.55M | 265.74M | |
Invested capital | 0.33 | 0.32 | 0.31 | 0.32 | 0.37 | |
Average receivables | 1.12B | 922.81M | 646.84M | 573.16M | 516.71M | |
Average payables | 706.74M | 532.7M | 334.54M | 328.3M | 330.92M | |
Average inventory | -1.01B | -829.79M | -457.29M | -373.07M | -1.69B | |
Days sales outstanding | 100.54 | 42.08 | 35.91 | 33.69 | 31.08 | |
Days payables outstanding | 0 | -19.93K | 50.3K | -982.35K | 0 | |
Days of inventory on hand | 0 | 29.34K | -63.29K | 995.79K | 0 | |
Receivables turnover | 0.9 | 2.14 | 2.51 | 2.67 | 2.9 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | -0.25 | -0.04 | -0.02 | -0.07 | -0.19 | |
Capex per share | -0.03 | -0.03 | -0.03 | -0.03 | -0.03 |
OSCR Frequently Asked Questions
What is Oscar Health, Inc. stock symbol ?
Oscar Health, Inc. is a US stock , located in New york of Ny and trading under the symbol OSCR
Is Oscar Health, Inc. buy or a sell ?
5 stock analysts have 5 predictions with a medium analyst target price of $10. The lowest prediction is $4 and the highest is $20
What is OSCR stock prediction ?
With a median analyst target price of $20, 1 stock analysts have made 1 forecasts in last 90 days. $20 is the lowest and $20 is the greatest projection.
What is Oscar Health, Inc. stock quote today ?
Oscar Health, Inc. stock price is $14.9595 today.
Is Oscar Health, Inc. stock public?
Yes, Oscar Health, Inc. is a publicly traded company.